Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci

The emergence of multidrug-resistant strains of Streptococcus pneumoniae drives the development and evaluation of new antipneumococcal agents, especially for the treatment of bacterial meningitis. The aims of the present study were to assess the antibacterial effectiveness of two new quinolones, gar...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Rodriguez-Cerrato, Violeta, McCoig, Cindy C., Saavedra, Jesus, Barton, Tess, Michelow, Ian C., Hardy, Robert D., Bowlware, Karen, Iglehart, Janie, Katz, Kathy, McCracken, George H.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC148949/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499193/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.211-215.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!